Hub : Traits

Short access day 10 total inactive lever presses

Tags: Behavior · Cocaine · Short access

Project: p50_paul_meyer_2020

4 loci · 5 genes with independent associations · 6 total associated genes

Significant Loci

#	Chr	Start pos	End pos	# assoc genes	# joint models	Best TWAS P	Best GWAS P	Cond GWAS P	Joint genes
1	chr3	106655041	109088906	3	2	3.54e-09	3.89e-02	2.36e-01	Catsper2 Ganc
2	chr4	95890735	97085238	1	1	4.11e-10	5.36e-03	5.17e-08	Serbp1
3	chr8	108585012	109845634	1	1	2.58e-26	1.64e-03	1.00e+00	Klhdc8b
4	chr9	75969545	77365260	1	1	4.98e-12	4.78e-01	1.00e+00	Zfand2b

Pleiotropic Associations

Trait	Chi2 ratio	# genes+	# genes++	% genes++	Corr	Corr P	Genes
BMI with tail	13.63	2	2	40	0	1.00e+00	Klhdc8b Zfand2b
BMI without tail	22.74	4	2	40	0.18	8.19e-01	Ganc Klhdc8b Serbp1 Zfand2b
Body weight	20.7	1	1	20	0	1.00e+00	Klhdc8b
Epididymis fat weight	111.28	1	1	20	0	1.00e+00	Zfand2b
Heart weight	22.23	4	1	20	-0.33	5.83e-01	Catsper2 Ganc Klhdc8b Zfand2b
Left kidney weight	16.09	4	2	40	-0.67	3.26e-01	Catsper2 Ganc Klhdc8b Zfand2b
Right kidney weight	16.88	5	2	40	-0.52	3.65e-01	Catsper2 Ganc Klhdc8b Serbp1 Zfand2b
Tail length	45.53	3	1	20	0	1.00e+00	Klhdc8b Serbp1 Zfand2b
Length with tail	4.88	4	1	20	-0.6	3.97e-01	Catsper2 Klhdc8b Serbp1 Zfand2b
Length without tail	77.43	1	1	20	0	1.00e+00	Zfand2b
Liver weight, left	10.62	2	0	0	0	1.00e+00	Klhdc8b Serbp1
Liver weight, right	17.57	1	1	20	0	1.00e+00	Zfand2b
Parametrial fat weight	9.99	1	0	0	0	1.00e+00	Zfand2b
Retroperitoneal fat weight	5.64	3	0	0	0	1.00e+00	Klhdc8b Serbp1 Zfand2b
Intraocular pressure	17.77	4	1	20	-0.95	1.20e-02	Catsper2 Ganc Serbp1 Zfand2b
Soleus weight	8.84	1	0	0	0	1.00e+00	Klhdc8b
Tibia length	6.9	2	1	20	0	1.00e+00	Ganc Klhdc8b
Number of licking bursts	28.51	2	2	40	0	1.00e+00	Klhdc8b Zfand2b
Food consumed during 24 hour testing period	12.4	2	0	0	0	1.00e+00	Klhdc8b Zfand2b
Times rat made contact with spout	9.25	1	0	0	0	1.00e+00	Zfand2b
Mean time between licks in bursts	7.18	2	0	0	0	1.00e+00	Klhdc8b Zfand2b
Mean num. licks in bursts	14.92	2	0	0	0	1.00e+00	Klhdc8b Zfand2b
Std. dev. time between licks in bursts	12.12	1	0	0	0	1.00e+00	Zfand2b
Water consumed over 24 hours	21.34	2	1	20	0	1.00e+00	Klhdc8b Zfand2b
Patch foraging indifference point 0 sec	9.99	2	0	0	0	1.00e+00	Klhdc8b Zfand2b
Patch foraging indifference point AUC	18.18	2	1	20	0	1.00e+00	Serbp1 Zfand2b
Indifference point function ln k	45.4	2	2	40	0	1.00e+00	Klhdc8b Zfand2b
Indifference point function log k	45.4	2	2	40	0	1.00e+00	Klhdc8b Zfand2b
Patch foraging total patch changes 0 sec	12.33	3	1	20	0	1.00e+00	Ganc Klhdc8b Zfand2b
Patch foraging total patch changes 18 sec	29.61	2	1	20	0	1.00e+00	Serbp1 Zfand2b
Patch foraging total patch changes 24 sec	42.08	2	1	20	0	1.00e+00	Klhdc8b Zfand2b
Patch foraging total patch changes 6 sec	16.1	2	1	20	0	1.00e+00	Serbp1 Zfand2b
Patch foraging time to switch 0 sec	20.1	2	1	20	0	1.00e+00	Klhdc8b Zfand2b
Patch foraging water rate 0 sec	22.99	2	1	20	0	1.00e+00	Serbp1 Zfand2b
Patch foraging water rate 12 sec	69.49	1	1	20	0	1.00e+00	Zfand2b
Patch foraging water rate 18 sec	7.63	2	0	0	0	1.00e+00	Serbp1 Zfand2b
Patch foraging water rate 24 sec	12.61	1	0	0	0	1.00e+00	Zfand2b
Patch foraging water rate 6 sec	35.43	1	1	20	0	1.00e+00	Zfand2b
Locomotor activity	35.08	2	1	20	0	1.00e+00	Klhdc8b Zfand2b
Locomotor testing distance	55.86	2	2	40	0	1.00e+00	Klhdc8b Zfand2b
Locomotor testing rearing	99.51	1	1	20	0	1.00e+00	Zfand2b
Light reinforcement 1	13.88	2	1	20	0	1.00e+00	Serbp1 Zfand2b
Light reinforcement 2	6.91	3	0	0	0	1.00e+00	Klhdc8b Serbp1 Zfand2b
Reaction time number correct	66.72	2	2	40	0	1.00e+00	Klhdc8b Zfand2b
Reaction time mean minus median	179.03	1	1	20	0	1.00e+00	Zfand2b
Reaction time mean minus median AUC	232.47	1	1	20	0	1.00e+00	Zfand2b
Reaction time num false alarms	5.73	2	0	0	0	1.00e+00	Klhdc8b Zfand2b
Reaction time num false alarms AUC	17.01	2	1	20	0	1.00e+00	Klhdc8b Zfand2b
Reaction time trials correct on left	66.72	2	2	40	0	1.00e+00	Klhdc8b Zfand2b
Reaction time trials on left	63.1	2	2	40	0	1.00e+00	Klhdc8b Zfand2b
Reaction time mean	36.11	1	1	20	0	1.00e+00	Zfand2b
Reaction time mean AUC	21.6	2	1	20	0	1.00e+00	Klhdc8b Zfand2b
Median of all reaction times	14.09	2	0	0	0	1.00e+00	Klhdc8b Zfand2b
Reaction time omissions	35.15	2	2	40	0	1.00e+00	Klhdc8b Zfand2b
Reaction time false alarm rate	20.24	1	1	20	0	1.00e+00	Klhdc8b
Reaction time premature initiations	17.81	3	1	20	0	1.00e+00	Klhdc8b Serbp1 Zfand2b
Std. dev. reaction times	72.92	1	1	20	0	1.00e+00	Zfand2b
Reaction time trials completed	63.1	2	2	40	0	1.00e+00	Klhdc8b Zfand2b
Reaction time trials AUC	64.7	2	2	40	0	1.00e+00	Klhdc8b Zfand2b
Social response proportion	17.1	1	0	0	0	1.00e+00	Catsper2
Conditioned locomotion	28.4	1	1	20	0	1.00e+00	Klhdc8b
Cocaine response after cond. corrected	10.86	2	0	0	0	1.00e+00	Catsper2 Zfand2b
Cocaine response after cond. not corrected	11.35	3	0	0	0	1.00e+00	Catsper2 Klhdc8b Zfand2b
Cocaine response before conditioning	38.66	1	1	20	0	1.00e+00	Klhdc8b
Saline control response	8.43	1	0	0	0	1.00e+00	Zfand2b
Condit. Reinf. active responses	5.1	1	0	0	0	1.00e+00	Catsper2
Condit. Reinf. lever presses	5.55	1	0	0	0	1.00e+00	Zfand2b
Condit. Reinf. lever reinforcers received	6.87	1	0	0	0	1.00e+00	Catsper2
Pavlov. Cond. change in total contacts	7.3	1	0	0	0	1.00e+00	Catsper2
Pavlov. Cond. magazine entry number	18.47	2	1	20	0	1.00e+00	Catsper2 Klhdc8b
Pavlov. Cond. intertrial magazine entries	6.56	2	0	0	0	1.00e+00	Catsper2 Klhdc8b
Pavlov. Cond. response bias	5.18	1	0	0	0	1.00e+00	Klhdc8b
Conditioned reinforcement - actives	152.54	1	1	20	0	1.00e+00	Zfand2b
Conditioned reinforcement - inactives	76.2	2	1	20	0	1.00e+00	Klhdc8b Zfand2b
Conditioned locomotion	11.22	2	0	0	0	1.00e+00	Serbp1 Zfand2b
Intermittent access intake day 1-15 change	156.77	1	1	20	0	1.00e+00	Zfand2b
Intermittent access intake escalation	117.41	1	1	20	0	1.00e+00	Zfand2b
Intermitt. access day 1 inactive lever presses	64.85	3	1	20	0	1.00e+00	Catsper2 Klhdc8b Zfand2b
Intermitt. access day 15 inactive lever presses	110.78	3	2	40	0	1.00e+00	Catsper2 Klhdc8b Zfand2b
Intermittent access day 1 total infusions	29.95	3	1	20	0	1.00e+00	Klhdc8b Serbp1 Zfand2b
Intermittent access day 15 total infusions	20.24	3	1	20	0	1.00e+00	Klhdc8b Serbp1 Zfand2b
Intermittent access terminal intake (last 3 days)	28.74	3	2	40	0	1.00e+00	Klhdc8b Serbp1 Zfand2b
Intermittent access total infusions	12.7	2	0	0	0	1.00e+00	Klhdc8b Serbp1
Intermittent access day 1 locomotion	18.98	2	1	20	0	1.00e+00	Klhdc8b Zfand2b
Intermittent access day 15 total locomotion	36.49	2	1	20	0	1.00e+00	Catsper2 Zfand2b
Intermittent access total locomotion	10.21	2	0	0	0	1.00e+00	Catsper2 Zfand2b
Intermittent access standard deviation	229.66	2	1	20	0	1.00e+00	Klhdc8b Zfand2b
Cocaine induced anxiety	36.56	4	1	20	-0.23	7.04e-01	Catsper2 Ganc Klhdc8b Zfand2b
Baseline Anxiety	393.92	1	1	20	0	1.00e+00	Zfand2b
Lifetime Intake	9.99	2	0	0	0	1.00e+00	Klhdc8b Serbp1
Incentive Sensitization - Responses	309.83	1	1	20	0	1.00e+00	Zfand2b
Incentive Sensitization - Breakpoint	300.45	1	1	20	0	1.00e+00	Zfand2b
Progressive ratio test 1 active lever presses	24.62	2	1	20	0	1.00e+00	Serbp1 Zfand2b
Progressive ratio test 1 breakpoint	24.19	2	1	20	0	1.00e+00	Serbp1 Zfand2b
Progressive ratio test 1 inactive lever presses	10.5	3	0	0	0.98	1.57e-02	Catsper2 Klhdc8b Serbp1
Progressive ratio test 2 active lever presses	33.6	3	1	20	-0.16	8.41e-01	Catsper2 Serbp1 Zfand2b
Progressive ratio test 2 breakpoint	41.13	3	1	20	0	1.00e+00	Catsper2 Serbp1 Zfand2b
Progressive ratio test 2 inactive lever presses	27.02	3	1	20	0	1.00e+00	Klhdc8b Serbp1 Zfand2b
Total sessions with >9 infusions	28.08	2	1	20	0	1.00e+00	Klhdc8b Serbp1
Short access day 1 total inactive lever presses	28.76	3	1	20	0	1.00e+00	Klhdc8b Serbp1 Zfand2b
Short access day 1 total infusions	18.8	1	0	0	0	1.00e+00	Serbp1
Short access day 10 total infusions	13.17	1	0	0	0	1.00e+00	Klhdc8b
Short access total infusions	9.9	1	0	0	0	1.00e+00	Serbp1
Short access day 1 locomotion	49.81	3	1	20	0	1.00e+00	Klhdc8b Serbp1 Zfand2b
Short access day 10 total locomotion	432.47	1	1	20	0	1.00e+00	Zfand2b
Short access total locomotion	209.96	1	1	20	0	1.00e+00	Zfand2b
Compulsive drug intake	40.41	2	1	20	0	1.00e+00	Serbp1 Zfand2b
One hour access (0.3 mA shock)	18.01	2	0	0	0	1.00e+00	Klhdc8b Zfand2b
One hour access (shock baseline)	7.82	2	0	0	0	1.00e+00	Catsper2 Klhdc8b
Number of responses in last shaping day	37.42	2	1	20	0	1.00e+00	Serbp1 Zfand2b
Locomotion distance, session 1	23.98	1	1	20	0	1.00e+00	Klhdc8b
Locomotion velocity, session 2	10	1	0	0	0	1.00e+00	Klhdc8b
Locomotion distance, session 2	33.15	1	1	20	0	1.00e+00	Klhdc8b
Locomotion velocity, session 3	11.69	2	0	0	0	1.00e+00	Catsper2 Klhdc8b
Locomotion distance, session 3	14.51	1	0	0	0	1.00e+00	Klhdc8b
Stereotopy head waving duration, day 3	6.96	1	0	0	0	1.00e+00	Klhdc8b
Locomotion velocity, session 8	9.36	1	0	0	0	1.00e+00	Klhdc8b
Locomotion distance, session 8	18.11	3	1	20	-0.24	7.57e-01	Catsper2 Ganc Klhdc8b
Degree of sensitization distance	16.2	2	0	0	0	1.00e+00	Catsper2 Klhdc8b
Condit. Reinf. active minus inactive responses	35.59	1	1	20	0	1.00e+00	Klhdc8b
Condit. Reinf. active-inactive response ratio	25.6	1	1	20	0	1.00e+00	Klhdc8b
Condit. Reinf. active responses	18.23	1	0	0	0	1.00e+00	Klhdc8b
Incentive salience index mean	26.23	1	1	20	0	1.00e+00	Klhdc8b
Condit. Reinf. lever presses	10.81	1	0	0	0	1.00e+00	Klhdc8b
Time in familiar zone, hab. session 1	63.49	1	1	20	0	1.00e+00	Klhdc8b
Time in novel zone, hab. session 1	13.1	1	0	0	0	1.00e+00	Klhdc8b
Total zone transitions, hab. session 1	37.38	1	1	20	0	1.00e+00	Klhdc8b
Total locomotion distance, hab. session 1	10.76	1	0	0	0	1.00e+00	Klhdc8b
Locomotion velocity, hab. session 1	10.22	1	0	0	0	1.00e+00	Klhdc8b
Time in familiar zone, hab. session 2	27.1	1	1	20	0	1.00e+00	Klhdc8b
Time in novel zone, hab. session 2	10.13	1	0	0	0	1.00e+00	Klhdc8b
Total zone transitions, hab. session 2	69.58	1	1	20	0	1.00e+00	Klhdc8b
Total locomotion distance, hab. session 2	19.2	1	0	0	0	1.00e+00	Klhdc8b
Locomotion velocity, hab. session 2	21.15	1	1	20	0	1.00e+00	Klhdc8b
Novel to familiar place preference ratio	22.33	1	0	0	0	1.00e+00	Klhdc8b
Novelty place preference	20.99	1	0	0	0	1.00e+00	Klhdc8b
Time in novel zone, NPP test	17.06	1	0	0	0	1.00e+00	Klhdc8b
Total zone transitions, NPP test	106.24	1	1	20	0	1.00e+00	Klhdc8b
Total locomotion distance, NPP test	27.88	2	1	20	0	1.00e+00	Ganc Klhdc8b
Locomotion velocity, NPP test	29.42	2	1	20	0	1.00e+00	Ganc Klhdc8b
Pavlov. Cond. magazine entry latency	9.23	2	0	0	0	1.00e+00	Catsper2 Ganc
Pavlov. Cond. change in total contacts	26.74	3	1	20	1	4.80e-03	Catsper2 Ganc Klhdc8b
Pavlov. Cond. index score	9.85	2	0	0	0	1.00e+00	Catsper2 Klhdc8b
Pavlov. Cond. latency score	7.28	2	0	0	0	1.00e+00	Catsper2 Klhdc8b
Pavlov. Cond. magazine entry number	8.41	3	0	0	-0.99	1.21e-02	Catsper2 Ganc Klhdc8b
Pavlov. Cond. intertrial magazine entries	13.1	2	0	0	0	1.00e+00	Catsper2 Ganc
Pavlov. Cond. lever-magazine prob. diff.	10.43	2	0	0	0	1.00e+00	Ganc Klhdc8b
Pavlov. Cond. response bias	8.27	3	0	0	0.98	2.04e-02	Catsper2 Ganc Klhdc8b
Bone: cortical thickness	6.45	1	0	0	0	1.00e+00	Catsper2
Bone: endosteal estimation	4	1	0	0	0	1.00e+00	Klhdc8b
Bone: final force	4.4	1	0	0	0	1.00e+00	Klhdc8b
Bone: maximum force	7.19	1	0	0	0	1.00e+00	Klhdc8b
Bone: stiffness	13.41	1	0	0	0	1.00e+00	Klhdc8b
Breakpoint value in progressive ratio session	6.62	1	0	0	0	1.00e+00	Catsper2
Distance traveled after self-admin	8.9	1	0	0	0	1.00e+00	Zfand2b
Delta time in closed arm before/after self-admin	10.4	3	0	0	0	1.00e+00	Catsper2 Klhdc8b Serbp1
Delta time in open arm before/after self-admin	25.12	2	0	0	0	1.00e+00	Serbp1 Zfand2b
Diff in mean of infusions in LGA sessions	18.85	1	0	0	0	1.00e+00	Serbp1
Active lever presses in extinction session 6	20.91	3	1	20	0	1.00e+00	Klhdc8b Serbp1 Zfand2b
Time in closed arm before self-admin	23.95	3	1	20	0	1.00e+00	Ganc Serbp1 Zfand2b
Time in closed arm after self-admin	7.53	1	0	0	0	1.00e+00	Serbp1
Time in open arm before self-admin	24.67	1	0	0	0	1.00e+00	Zfand2b
Sum of active levers in priming session hrs 5-6	8.73	1	0	0	0	1.00e+00	Serbp1
Time to tail flick, vehicle, before self-admin	14.83	1	0	0	0	1.00e+00	Serbp1
Time to tail flick, vehicle, after self-admin	54.72	3	3	60	0	1.00e+00	Klhdc8b Serbp1 Zfand2b
Time to tail flick, test, before self-admin	10.68	1	0	0	0	1.00e+00	Zfand2b
Delta time to tail flick, vehicle, before/after SA	32.97	3	1	20	0	1.00e+00	Klhdc8b Serbp1 Zfand2b
Ambulatory time before self-admin	25.36	1	0	0	0	1.00e+00	Zfand2b
Ambulatory time after self-admin	17.94	1	0	0	0	1.00e+00	Serbp1
Total heroin consumption	14.8	2	0	0	0	1.00e+00	Klhdc8b Serbp1
Area under the delay curve	20.1	2	1	20	0	1.00e+00	Catsper2 Zfand2b
Delay disc. indifference point, 0s delay	28.7	1	1	20	0	1.00e+00	Klhdc8b
Delay disc. indifference point, 16s delay	27.46	3	1	20	-0.53	4.66e-01	Catsper2 Klhdc8b Zfand2b
Delay disc. indifference point, 24s delay	27.43	1	0	0	0	1.00e+00	Zfand2b
Delay disc. indifference point, 4s delay	41.82	1	1	20	0	1.00e+00	Klhdc8b
Delay disc. indifference point, 8s delay	35.22	2	1	20	0	1.00e+00	Catsper2 Zfand2b
Delay discount exponential model param	16.14	1	0	0	0	1.00e+00	Zfand2b
Delay discount hyperbolic model param	15.89	1	0	0	0	1.00e+00	Zfand2b
Fecal boli incidents, locomotor time 1	66.69	3	1	20	0	1.00e+00	Catsper2 Klhdc8b Zfand2b
Change in fecal boli incidents, locomotor task	13.85	1	0	0	0	1.00e+00	Serbp1
Time >=10cm from walls, locomotor time 1	43.35	2	1	20	0	1.00e+00	Klhdc8b Zfand2b
Rest time, locomotor task time 1	16.92	3	0	0	0	1.00e+00	Klhdc8b Serbp1 Zfand2b
Distance moved, locomotor task time 1	31.01	1	1	20	0	1.00e+00	Klhdc8b
Vertical activity count, locomotor time 1	52.92	3	2	40	0	1.00e+00	Klhdc8b Serbp1 Zfand2b
Time >=10cm from walls, locomotor time 2	7.06	1	0	0	0	1.00e+00	Catsper2
Bouts of movement, locomotor time 2	17.12	3	0	0	0	1.00e+00	Ganc Klhdc8b Zfand2b
Total resting periods, locomotor time 2	21.64	3	1	20	0	1.00e+00	Ganc Klhdc8b Zfand2b
Rest time, locomotor task time 2	35.13	2	2	40	0	1.00e+00	Klhdc8b Zfand2b
Distance moved, locomotor task time 2	63.13	2	2	40	0	1.00e+00	Klhdc8b Zfand2b
Vertical activity count, locomotor time 2	24.95	3	1	20	0	1.00e+00	Klhdc8b Serbp1 Zfand2b
Weight adjusted by age	20.12	2	1	20	0	1.00e+00	Klhdc8b Zfand2b
Seeking ratio, delayed vs. immediate footshock	7.36	2	0	0	0	1.00e+00	Catsper2 Zfand2b
Locomotion in novel chamber post-restriction	16.14	2	0	0	0	1.00e+00	Serbp1 Zfand2b
Progressive ratio	7.25	1	0	0	0	1.00e+00	Klhdc8b
Food seeking constrained by brief footshock	13.85	2	0	0	0	1.00e+00	Klhdc8b Zfand2b
Run reversals in cocaine runway, females	36.45	1	1	20	0	1.00e+00	Zfand2b
Latency to leave start box in cocaine runway	34.23	1	1	20	0	1.00e+00	Zfand2b
Latency to leave start box in cocaine runway, F	31.9	1	1	20	0	1.00e+00	Zfand2b
Latency to leave start box in cocaine runway, M	9.03	1	0	0	0	1.00e+00	Catsper2
Cd content in liver	20.17	1	0	0	0	1.00e+00	Klhdc8b
Fe content in liver	40.39	1	1	20	0	1.00e+00	Klhdc8b
K content in liver	12.22	1	0	0	0	1.00e+00	Klhdc8b
Mg content in liver	15.79	1	0	0	0	1.00e+00	Klhdc8b
Na content in liver	11.55	2	0	0	0	1.00e+00	Catsper2 Klhdc8b
Rb content in liver	51.88	1	1	20	0	1.00e+00	Klhdc8b
Se content in liver	8.45	1	0	0	0	1.00e+00	Klhdc8b
Sr content in liver	22.41	1	0	0	0	1.00e+00	Klhdc8b
Zn content in liver	9.95	1	0	0	0	1.00e+00	Klhdc8b

Associations by panel

Tissue	RNA modality	# hits	% hits/tests	Avg chisq
Adipose	alternative polyA	0	0	1.03
Adipose	alternative TSS	0	0	1.11
Adipose	gene expression	0	0	1.1
Adipose	isoform ratio	0	0	1.07
Adipose	intron excision ratio	0	0	1.07
Adipose	mRNA stability	0	0	1.07
BLA	alternative polyA	0	0	1.18
BLA	alternative TSS	0	0	1.16
BLA	gene expression	0	0	1.13
BLA	isoform ratio	1	0	1.14
BLA	intron excision ratio	0	0	1.1
BLA	mRNA stability	0	0	1.18
Brain	alternative polyA	0	0	1.11
Brain	alternative TSS	0	0	1.11
Brain	gene expression	0	0	1.08
Brain	isoform ratio	0	0	1.11
Brain	intron excision ratio	0	0	1.08
Brain	mRNA stability	0	0	1.11
Eye	alternative polyA	0	0	1.25
Eye	alternative TSS	0	0	0.93
Eye	gene expression	0	0	1.11
Eye	isoform ratio	0	0	1.22
Eye	intron excision ratio	0	0	1.11
Eye	mRNA stability	0	0	1.11
IL	alternative polyA	0	0	1.06
IL	alternative TSS	0	0	1.04
IL	gene expression	0	0	1.1
IL	isoform ratio	0	0	1.11
IL	intron excision ratio	0	0	1.12
IL	mRNA stability	0	0	1.15
LHb	alternative polyA	0	0	1.03
LHb	alternative TSS	0	0	1.14
LHb	gene expression	0	0	1.06
LHb	isoform ratio	0	0	1.09
LHb	intron excision ratio	0	0	1.17
LHb	mRNA stability	0	0	1.16
Liver	alternative polyA	0	0	1.04
Liver	alternative TSS	0	0	1.11
Liver	gene expression	1	0	1.11
Liver	isoform ratio	1	0	1.11
Liver	intron excision ratio	0	0	1.16
Liver	mRNA stability	0	0	1.08
NAcc	alternative polyA	0	0	1.17
NAcc	alternative TSS	0	0	1.21
NAcc	gene expression	0	0	1.11
NAcc	isoform ratio	0	0	1.16
NAcc	intron excision ratio	1	0	1.11
NAcc	mRNA stability	0	0	1.14
OFC	alternative polyA	0	0	1.02
OFC	alternative TSS	0	0	1.03
OFC	gene expression	0	0	1.1
OFC	isoform ratio	0	0	1.1
OFC	intron excision ratio	0	0	1.08
OFC	mRNA stability	0	0	1.11
PL	alternative polyA	0	0	1.16
PL	alternative TSS	0	0	1.2
PL	gene expression	0	0	1.12
PL	isoform ratio	0	0	1.17
PL	intron excision ratio	2	0	1.11
PL	mRNA stability	0	0	1.15
pVTA	alternative polyA	0	0	1.05
pVTA	alternative TSS	0	0	1.19
pVTA	gene expression	0	0	1.1
pVTA	isoform ratio	0	0	1.13
pVTA	intron excision ratio	0	0	1.08
pVTA	mRNA stability	0	0	1.19
RMTg	alternative polyA	0	0	1.17
RMTg	alternative TSS	0	0	1.05
RMTg	gene expression	0	0	1.06
RMTg	isoform ratio	0	0	1.21
RMTg	intron excision ratio	0	0	1.17
RMTg	mRNA stability	0	0	1.03